HARROW, INC. — Director's Dealing 2012

Dec 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-14

Reporting Person: Bassani August Shelby (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-14	Option - Right to Buy	$2.15	A	38014	Acquired	2017-12-14	Common Stock (38014)	Direct

Footnotes

F1: The vesting period of the option commences on January 1, 2013 with 1/12 of the shares underlying the option to vest on each monthly anniversary of the vesting commencement date until all such shares have vested.